Mats Hammar赞助的临床试验
总计659个结果
-
Marcela V. Maus, M.D.,Ph.D.招聘中滤泡性淋巴瘤 | 套细胞淋巴瘤 | 边缘区淋巴瘤 | 弥漫性大 B 细胞淋巴瘤 | 难治性非霍奇金淋巴瘤 | 原发性纵隔大 B 细胞淋巴瘤 (PMBCL) | 非霍奇金淋巴瘤 | 高级别 B 细胞淋巴瘤 | 3b 级滤泡性淋巴瘤 | 复发性非霍奇金淋巴瘤美国
-
Y-mAbs TherapeuticsMemorial Sloan Kettering Cancer Center终止
-
Memorial Sloan Kettering Cancer CenterY-mAbs Therapeutics主动,不招人
-
Federal University of Mato GrossoUnivag Centro Universitário完全的
-
King's College LondonMedical Research Council; Mars, Inc.完全的
-
Mast Therapeutics, Inc.University of California, San Diego完全的
-
Hamad Medical Corporation招聘中
-
Hamad Medical Corporation尚未招聘
-
Hamad Medical Corporation招聘中
-
Hamad Medical Corporation完全的
-
Hamad Medical Corporation未知原发性血小板增多症 | 原发性骨髓纤维化,纤维化前期 | 原发性骨髓纤维化,纤维化阶段卡塔尔
-
Hamad Medical Corporation未知
-
Marcela V. Maus, M.D.,Ph.D.完全的
-
Memorial Sloan Kettering Cancer CenterY-mAbs Therapeutics主动,不招人
-
Y-mAbs TherapeuticsMemorial Sloan Kettering Cancer Center完全的
-
Memorial Sloan Kettering Cancer CenterY-mAbs Therapeutics主动,不招人
-
Gordon Sussman Clinical ResearchMast Cell Pharmaceuticals Inc.未知